Consensus American Well Corporation

Stocks

AMWL

US03044L2043

Healthcare Facilities & Services

Market Closed - NYSE 16:00:02 2026-10-21 EDT			5-day change	1st Jan Change
13.97 ^USD	+5.83%		+14.98%	+184.52%

09-16	American Well Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 01:05 PM
09-08	American Well Corporation Receives Letter Of Intent From Department Of Veterans Affairs To Deploy Virtual Health Platform	CI

Evolution of the Average Target: American Well Corporation

Evolution of the Target Price: American Well Corporation

Changes in Analyst Recommendations: American Well Corporation

e29c2abfceb25b.DcsHNagcBkjZWc0IEnZT63a6ALyEec1L0IE_H5Gq_H0.NKY1BPlVSACJa45QXB0LuELPUcrKGJwfke5RT-n-yB44pENhy1k2JYY3vg~0b31abc87ad29bf79cdbf38d33c84a98

Analysts' recommendations: American Well Corporation

08-13	Truist Adjusts American Well's Price Target to $12 From $7.50, Keeps Hold Rating	MT
11-13	Truist Removes $7.50 Price Target on American Well, Cites Share Volatility, Low Share Price; Hold Rating Kept	MT
25-04-10	Truist Cuts Price Target on American Well to $7.50 From $12, Keeps Hold Rating	MT
25-02-14	Truist Securities Adjusts Price Target on American Well to $12 From $10, Keeps Hold Rating	MT
25-01-13	Wells Fargo Upgrades American Well to Overweight From Equalweight, Price Target is $15	MT
24-12-17	Morgan Stanley Adjusts Price Target on American Well to $10.50 From $20	MT
24-05-23	UBS Adjusts American Well Price Target to $0.60 From $1.50, Maintains Neutral Rating	MT
24-04-15	Morgan Stanley Adjusts American Well's Price Target to $1 From $1.75, Keeps Equalweight Rating	MT
23-11-08	UBS Adjusts American Well Price Target to $1.30 From $2.60, Maintains Neutral Rating	MT
23-08-04	UBS Adjusts Price Target on American Well to $2.60 From $2.80, Maintains Neutral Rating	MT
23-08-03	Morgan Stanley Downgrades American Well to Equalweight From Overweight, Halves PT to $2.50 From $5, Cites Weaker-Than-Expected Growth	MT
23-05-04	Credit Suisse Trims American Well's Price Target to $3.50 From $4 After Lower-Than-Expected Q1 Results, Keeps Neutral Rating	MT
23-03-23	TD Cowen Downgrades American Well to Market Perform From Outperform, Adjusts Price Target to $2.50 From $5	MT
23-03-13	Morgan Stanley Adjusts Price Target on American Well to $5 From $6, Maintains Overweight Rating	MT
23-02-28	UBS Adjusts American Well Price Target to $3.10 From $4.20, Maintains Neutral Rating	MT
23-02-27	Piper Sandler Downgrades American Well to Neutral From Overweight, Adjusts Price Target to $3.50 From $5	MT
23-02-23	Credit Suisse Trims American Well's Price Target to $4 From $5 on Lower-Than-Expected 2023 Outlook, Keeps Neutral Rating	MT
23-01-06	Morgan Stanley Cuts Price Target on American Well to $6 From $7, Reiterates Overweight Rating	MT
23-01-04	BofA Securities Upgrades American Well to Buy From Neutral, Price Target is $4.20	MT
22-09-07	Truist Securities Starts American Well at Hold With $5 Price Target	MT
22-09-07	Piper Sandler Adjusts American Well's Price Target to $5 From $6, Reiterates Overweight Rating	MT
22-08-08	UBS Adjusts American Well Price Target to $4.20 From $3.25, Maintains Neutral Rating	MT
22-07-01	Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	MT
22-06-23	Piper Sandler Adjusts American Well's Price Target to $6 From $5, Maintains Overweight Rating	MT
22-05-26	Goldman Sachs Adjusts Price Target for American Well to $4.50 From $5, Maintains Neutral Rating	MT

More recommendations

Telemedicine Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AMERICAN WELL CORPORATION					-3.03%
	CVS HEALTH CORPORATION					+21.88%
	HCA HEALTHCARE, INC.					-1.11%
	NATERA, INC.					+0.9%
	FRESENIUS SE & CO. KGAA					+23.76%
	LABCORP HOLDINGS INC.					+6.81%
	QUEST DIAGNOSTICS INCORPORATED					+6.16%
	TENET HEALTHCARE CORPORATION					+5.17%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+22.33%
	REDE D'OR SÃO LUIZ S.A.					+12.38%
	Average					+9.53%
	Weighted average by Cap.					+10.43%